Literature DB >> 31030701

Thought-feeling discrimination in people with dementia: adaptation and preliminary validation of the first dementia-specific measure.

Joshua Stott1, Tim Cadman1, Henry Potts2, Katrina Scior1, Janina Brede1, Georgina Charlesworth1.   

Abstract

OBJECTIVE: There is emerging evidence that cognitive behavioral therapy (CBT) can be effective for treating anxiety and depression in people living with dementia (PLWD). Discriminating between thoughts and feelings is a critical element of CBT and also of relevance to emotional understanding more generally. The aim of the present study was the structured adaptation and preliminary validation of an existing measure of thought-feeling discrimination for use in PLWD. METHODS/
DESIGN: The Behavior Thought Feeling Questionnaire (BTFQ) was adapted via expert and service-user consultation for use in PLWD. One hundred two PLWD and 77 people aged over 65 years who did not have measurable cognitive impairments completed the adapted measure along with two measures of emotional recognition and reasoning. The factor structure of this measure was examined and the measure reduced.
RESULTS: Factor analysis suggested a two-factor solution with thought and feeling items loading on separate factors. The behavior items were not included in scoring due to high cross-loading and ceiling effects, leaving a 14-item measure with two subscales. Thus, an adapted measure was created (named the BTFQ-D), which showed moderate convergent validity in the PLWD but not the older adult sample. Both thought and feeling subscales showed good internal consistency.
CONCLUSIONS: The BTFQ-D showed preliminary validity as a measure of thought-feeling discrimination in PLWD. It may have utility in measuring readiness for CBT as part of clinical assessment. Further validation is required.

Entities:  

Keywords:  aging; anxiety; clinical assessment; cognitive behavioral therapy (CBT); mood disorders

Mesh:

Year:  2020        PMID: 31030701      PMCID: PMC7025873          DOI: 10.1017/S1041610219000322

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  35 in total

1.  The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2010-07       Impact factor: 6.437

2.  The nominal group as a research instrument for exploratory health studies.

Authors:  A H Van de Ven; A L Delbecq
Journal:  Am J Public Health       Date:  1972-03       Impact factor: 9.308

3.  Emotion recognition deficit in schizophrenia: association with symptomatology and cognition.

Authors:  C G Kohler; W Bilker; M Hagendoorn; R E Gur; R C Gur
Journal:  Biol Psychiatry       Date:  2000-07-15       Impact factor: 13.382

4.  Depression in dementia: epidemiology, mechanisms, and treatment.

Authors:  Daniela Enache; Bengt Winblad; Dag Aarsland
Journal:  Curr Opin Psychiatry       Date:  2011-11       Impact factor: 4.741

5.  Emotion-discrimination deficits in mild Alzheimer disease.

Authors:  Christian G Kohler; Gerri Anselmo-Gallagher; Warren Bilker; Jason Karlawish; Raquel E Gur; Christopher M Clark
Journal:  Am J Geriatr Psychiatry       Date:  2005-11       Impact factor: 4.105

6.  A framework for understanding modifications to measures for diverse populations.

Authors:  Anita L Stewart; Angela D Thrasher; Jack Goldberg; Judy A Shea
Journal:  J Aging Health       Date:  2012-04-10

7.  Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease.

Authors:  Sharpley Hsieh; Samantha Schubert; Christopher Hoon; Eneida Mioshi; John R Hodges
Journal:  Dement Geriatr Cogn Disord       Date:  2013-08-15       Impact factor: 2.959

Review 8.  Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

Authors:  Sube Banerjee; Jennifer Hellier; Michael Dewey; Renee Romeo; Clive Ballard; Robert Baldwin; Peter Bentham; Chris Fox; Clive Holmes; Cornelius Katona; Martin Knapp; Claire Lawton; James Lindesay; Gill Livingston; Niall McCrae; Esme Moniz-Cook; Joanna Murray; Shirley Nurock; Martin Orrell; John O'Brien; Michaela Poppe; Alan Thomas; Rebecca Walwyn; Kenneth Wilson; Alistair Burns
Journal:  Lancet       Date:  2011-07-19       Impact factor: 79.321

Review 9.  Dementia prevention, intervention, and care.

Authors:  Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2017-07-20       Impact factor: 202.731

10.  Using computers to teach people with intellectual disabilities to perform some of the tasks used within cognitive behavioural therapy: A randomised experiment.

Authors:  Leen Vereenooghe; Lina Gega; Shirley Reynolds; Peter E Langdon
Journal:  Behav Res Ther       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.